您的位置: 美股首页 > Crinetics Pharmaceuticals Inc股票行情 > Crinetics Pharmaceuticals Inc公司档案
- 美东时间:8月23日 01:50:15
- 北京时间:8月23日 01:50:15
- 东京时间:8月23日 01:50:15
- 伦敦时间:8月23日 01:50:15
今开: |
涨跌: |
最高: |
市值(亿美元): |
昨收: |
涨跌幅: |
最低: |
市盈率: |
Crinetics Pharmaceuticals Inc公司介绍
证券代码: |
CRNX |
上市板: |
主板 |
证券名称: |
Crinetics Pharmaceuticals Inc |
上市场所: |
纳斯达克交易所 |
证券类型: |
普通股 |
发行方式: |
公开发售 |
首发上市日: |
2018/07/18 |
首发价格(元): |
17 |
首发数量(股): |
6,000,000 |
首发募资总额(USD/元): |
102,000,000.00 |
Crinetics Pharmaceuticals Inc基本资料
公司名称: |
Crinetics Pharmaceuticals, Inc. |
注册地址: |
美国特拉华州 |
证券名称: |
Crinetics Pharmaceuticals Inc |
上市场所: |
纳斯达克交易所 |
办公地址: |
10222 Barnes Canyon Road, Bldg. #2, San Diego, California, USA |
董事会主席: |
- |
成立日期: |
2008/11/18 |
公司属地: |
United States 美国 |
电话: |
+1 (858) 450-6464 |
公司网址: |
www.crinetics.com |
公司介绍: |
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Endocrine pathways function to maintain homeostasis and commonly use peptide hormones acting through G protein coupled receptors, or GPCRs, to regulate many aspects of physiology including growth, energy, metabolism, gastrointestinal function and stress responses. It has assembled a seasoned team with extensive expertise in drug discovery and development in endocrine GPCRs and built a highly productive drug discovery organization. |